Evidence map›Paper›PMID 33361525›Full record

ArticleAging2020

Dynamic monitoring of immune function indexes in COVID-19 patients.

Yaohui Song, Huixiu Zhong, Lin Li, Minggang Yin, Yi Yin, Xiaolong Guo, Bo Zhang, Weiping Liu

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yaohui SongDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Huixiu ZhongDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Lin LiDepartment of Laboratory Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China.
Minggang YinDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Yi YinDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Xiaolong GuoDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Bo ZhangDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Weiping LiuDepartment of Clinical Laboratory, Zigong First People’s Hospital, Zigong 643000, Sichuan, China.
Zigong First People's Hospital · CNSichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a retrospective analysis of the clinical characteristics and dynamic variations of immune indexes in nine COVID-19 patients in Zigong, China. We used flow cytometry and enzyme-linked immunosorbent assays to measure the absolute levels of CD4 and CD8 lymphocytes and SARS-CoV-2 antibodies, respectively. We found that CRP, LDH, HBDH, CD4/CD8 and IgE levels were increased in 6/9 patients, while PA and the absolute numbers of CD4 and CD8 lymphocytes decreased in 7/9 patients. From disease onset through 63 days of follow-up, SARS-CoV-2 IgG levels were consistently higher than those of SARS-CoV-2 IgM, reaching peaks on days 28 and 13, respectively. IgM levels decreased to normal 35 days after disease onset, while IgG levels remained elevated through day 63. IgE levels varied similarly to SARS-CoV-2 IgM. Our results suggest that SARS-CoV-2 may elicit allergic immune responses in patients and that the levels of CRP, PA, LDH, and HBDH, as well as the absolute numbers of CD4 and CD8 lymphocytes could be used as early diagnostic markers of SARS-CoV-2 infection. Lastly, the dynamic variation of SARS-CoV-2 antibodies could guide the timing of blood collection for plasma exchange.

Indexed as

AdultAntibodies, ViralBiomarkersCOVID-19Disease SusceptibilityEarly DiagnosisFemaleHost-Pathogen InteractionsHumansMaleMiddle AgedPublic Health SurveillanceRetrospective StudiesSARS-CoV-2Young AdultAntibodies, ViralBiomarkersCOVID-19dynamic monitoringearly diagnostic markersIgESARS-CoV-2 antibodies

Identifiers

PMID33361525
PMCPMC7803549
OpenAlexW3116311214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.